Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
40.30
+1.80 (4.68%)
Jun 18, 2026, 2:58 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 1.72 billion as of June 18, 2026. Its market cap has increased by 0.85% in one year.
Market Cap
1.72B
Enterprise Value
1.28B
Revenue
1.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.30
Market Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 1.72B, an increase of 16.09%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.72B | 24.89% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunhawk Vision Biotech | 2.00B |
| G&E Herbal Biotechnology | 1.98B |
| Sunny Pharmtech | 1.96B |
| 3D Global Biotech | 1.89B |
| Greenyn Biotechnology | 1.82B |
| Synbio Tech | 1.73B |
| TaiRx | 1.58B |
| Anti-Microbial Savior BioteQ | 1.55B |